New cholesterol guidelines push earlier, personalized heart-disease prevention
The 2026 ACC/AHA dyslipidemia guidelines call for earlier, more personalized cholesterol screening (even in children for familial hypercholesterolemia), broader risk assessment including genetic factors like Lp(a), and introduce a new PREVENT calculator to estimate 10- and 30-year cardiovascular risk, with expanded treatment options and lower LDL targets to prevent heart disease decades down the line.